Search - tctmd.com

Displaying 141 - 160 of 312

Sort: Relevancy | Date

Presentation NY Valves 2024

The SESAME Procedure for Obstructive HCM.

Presenter: Jaffar M. Khan

June 07, 2024

Presentation NY Valves 2024

A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy

Presenter: Martin Maron

June 07, 2024

News Conference News NY Valves 2024

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Todd Neale

June 07, 2024

News Conference News NY Valves 2024

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Michael O'Riordan

June 07, 2024

Presentation NY Valves 2024

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

Presenter: Tsuyoshi Kaneko

June 07, 2024

Presentation NY Valves 2024

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Helge Möllmann

June 07, 2024

Presentation NY Valves 2024

Ongoing Research Clinical Research – Impact on Future Guidelines?

Presenter: Dimosthenis Pandis

June 07, 2024

Presentation NY Valves 2024

What Is the Future of Percutaneous Tricuspid Valve Procedures?

Presenter: Eric Horlick

June 07, 2024

Presentation NY Valves 2024

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Bassem M. Chehab

June 07, 2024

Presentation NY Valves 2024

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

Presenter: Sebastian Ludwig

June 07, 2024

Presentation NY Valves 2024

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: John K. Forrest

June 07, 2024

Presentation NY Valves 2024

Tricuspid Valve Anatomy (and Pathology): Who Is a Candidate for Transcatheter Tricuspid Valve Edge-to-Edge Repair?

Presenter: D. Scott Lim

June 07, 2024

Presentation NY Valves 2024

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Presenter: Anita W. Asgar

June 07, 2024

Presentation NY Valves 2024

The SAPIEN Balloon-Expandable TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Pradeep K. Yadav

June 07, 2024

Presentation NY Valves 2024

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

Presenter: Steven J. Yakubov

June 07, 2024

Presentation NY Valves 2024

Percutaneous PVR II: What Technologies Are Coming, and How Will They Change Things?

Presenter: Barry A. Love

June 07, 2024

Presentation NY Valves 2024

New Design Features and Changing Clinical Topics for TAVR in the Next Decade!

Presenter: Tamim M. Nazif

June 07, 2024

Presentation NY Valves 2024

Anywhere But There: CIED Options (PPM/ICD) in Patients Following Tricuspid Valve Intervention

Presenter: Christopher Liu

June 07, 2024

Presentation NY Valves 2024

RV Function and the Pulmonary Circulation: Physiological Insights Influencing Clinical Decision Making in TR Treatment

Presenter: Karl-Philipp Rommel

June 07, 2024

Presentation NY Valves 2024

Extract or Go to Jail: CIED Lead Management in Patients Undergoing Tricuspid Valve Intervention

Presenter: Laurence Epstein

June 07, 2024

Advertisement

The SESAME Procedure for Obstructive HCM.

A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Ongoing Research Clinical Research – Impact on Future Guidelines?

What Is the Future of Percutaneous Tricuspid Valve Procedures?

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Tricuspid Valve Anatomy (and Pathology): Who Is a Candidate for Transcatheter Tricuspid Valve Edge-to-Edge Repair?

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

The SAPIEN Balloon-Expandable TAVR Program: Technology Focus and Clinical Trial Priorities

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

Percutaneous PVR II: What Technologies Are Coming, and How Will They Change Things?

New Design Features and Changing Clinical Topics for TAVR in the Next Decade!

Anywhere But There: CIED Options (PPM/ICD) in Patients Following Tricuspid Valve Intervention

RV Function and the Pulmonary Circulation: Physiological Insights Influencing Clinical Decision Making in TR Treatment

Extract or Go to Jail: CIED Lead Management in Patients Undergoing Tricuspid Valve Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content